Last edition
News about "Shilpa CDMO"
Shilpa CDMO to Invest USD 50 Million in Peptide Manufacturing Expansion
Shilpa CDMO's expanded facility will feature six parallel cGMP manufacturing lines, supporting solid-phase, liquid-phase and hybrid peptide synthesis.
Shilpa CDMO | 06/11/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members